Phase 1b Open-Label Study of Loncastuximab Tesirine in Combination with Other Anticancer Agents in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
Clinical Lymphoma Myeloma and Leukemia（2024）
Key words
ABCL,non-Hodgkin lymphoma,loncastuximab tesirine,glofitamab,mosunetuzumab,phase 1,trial-in-progress
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined